Monday, August 31, 2026

EUR/GBP Bullish Momentum: 0.56% Up Since The Last Session

ViaNews Editorial Team

January 6, 2021

EUR/GBP Bullish Momentum: 0.56% Up Since The Last Session

EUR/GBP is currently on bullish momentum. At 09:27 EST EST on Wednesday, 6 January, EUR/GBP is at £0.9075, 0.56% up since the last session's close.

EUR/GBP Range

EUR/GBP is 0.677% up from its last session low of £0.9014 and 0.243% up from its last session high of £0.9053.

Over the last three sessions, EUR/GBP's higher value was £0.9053 and the lower value was £0.8838.

Over the last seven sessions, EUR/GBP's higher value was £0.9091 and the lower value was £0.8838.

Over the last month, EUR/GBP's higher value was £0.9229 and the lower value was £0.8422.

EUR/GBP's yearly highs and lows, it's 9.588% up from its 52-week low and 4.413% down from its 52-week high.

Volatility

EUR/GBP's last day, last week, and last month's average volatility was a positive 0.8300%, a negative 0.1080%, and a negative 0.0048%, respectively.

EUR/GBP's last day, last week, and last month's high and low average amplitude percentage was 0.4300%, 0.7180%, and 1.1576%, respectively.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com